Compare MOV & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOV | CLPT |
|---|---|---|
| Founded | 1961 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 494.6M |
| IPO Year | N/A | 2009 |
| Metric | MOV | CLPT |
|---|---|---|
| Price | $23.29 | $11.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $31.50 | $21.50 |
| AVG Volume (30 Days) | 98.5K | ★ 927.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.01% | N/A |
| EPS Growth | N/A | ★ 22.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $31,390,000.00 |
| Revenue This Year | $2.30 | $18.93 |
| Revenue Next Year | $1.17 | $51.64 |
| P/E Ratio | $25.52 | ★ N/A |
| Revenue Growth | N/A | ★ 31.04 |
| 52 Week Low | $12.85 | $8.63 |
| 52 Week High | $25.85 | $30.10 |
| Indicator | MOV | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 46.40 |
| Support Level | $20.46 | $10.57 |
| Resistance Level | $25.54 | $14.80 |
| Average True Range (ATR) | 0.72 | 1.00 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 23.65 | 46.46 |
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.